1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Pharma-biotech Alliance Analysis

Global Pharma-biotech Alliance Analysis

  • May 2010
  • -
  • Frost & Sullivan

This IBD provides an overview of the pharma-biotech alliance deals struck from 2008 to present. This study covers deal structures by therapeutic area, stage of product development and deal type. Trends in alliances from selected pharmaceutical companies are also analyzed. This report provides detailed profiles of the key vendors in the industry such as AstraZeneca; Novartis AG; Roche; Merck; Pfizer; Sanofi-Aventis; Amgen and GSK. Within each company segment analysis, an in-depth analysis of the competitive situation, a therapeutic area wise focus and an analysis of top deals in the last two years is included. Finally, this study presents the market overview and summary of key findings.

Table Of Contents

Global Pharma-biotech Alliance Analysis
Table of Contents

Pharma-biotech Alliances
Introduction to Pharma-biotech Alliances
Challenges, Drivers and Restraints
Overview of Deals
Overview of Deals by Therapeutic Area
Overview of Deals by Stage of Development
Overview of Deals by Selected Companies
Future Direction
About Frost and Sullivan
Global Pharma-biotech Alliances
Pharma-biotech Alliances: Industry Challenges (World), 2010-2016
Pharma-biotech Alliances: Impact Probability Matrix for Challenges (World), 2010-2016
Pharma-biotech Alliances: Market Drivers (World), 2010-2016
Pharma-biotech Alliances: Market Restraints (World), 2010-2016
Pharma-biotech Alliances: Impact Mapping of Global Pharma-biotech Alliance Drivers and Restraints (World), 2010-2016
Pharma-biotech Alliances: Deal Volume for Pharma-Biotech MandA and Licensing Deals (World), 2009-2010
Pharma-biotech Alliances: Deal Type Break-up for Pharma-biotech Licensing Deals (World), 2005-2009
Pharma-biotech Alliances: Deal Analysis by Therapeutic Area (World), 2008-2010
Pharma-biotech Alliances: Percentage of Partnered Products By Stage of Drug Development (World), 2010
Pharma-biotech Alliances: AstraZeneca - Percentage of Partnered Products Versus Average Sales (World), 2008-2009
Pharma-biotech Alliances: Percentage of Drug Candidates by Phase of Drug Development (World), 2010
Pharma-biotech Alliances: AstraZeneca Potential Drug Candidates Filings (World), 2009-2014
Pharma-biotech Alliances: Percentage of Partnered Product in Pipeline (World), 2010
Pharma-biotech Alliances: Drug Candidates from Alliances (World), 2008 and 2009
Pharma-biotech Alliances: Novartis - Percentage of Partnered Products Versus Average Sales (World), 2008 and 2009
Pharma-biotech Alliances: Novartis - Percentage of Partnered Products in Drug Pipeline by Therapeutic Area (World), 2009Pharma-biotech Alliances: Novartis - Percentage of Partnered Product in Pipeline by Therapeutic Area (World), 2009
Pharma-biotech Alliances: Drug Candidates from Alliances and Partnerships (World), 2010
Pharma-biotech Alliances: Roche: Analysis of Deals Types (World), 2005-2008
Pharma-biotech Alliances: Roche - Percentage of Partnered Products Versus Average Sales (World), 2008
Pharma-biotech Alliances: Percentage of Partnered Compounds by Phase of Drug Development (World), 2010
Pharma-biotech Alliances: Percentage of Total Drug Candidates by Phase of Drug Development (World), 2010
Pharma-biotech Alliances: Percentage Of Drug Candidates In Pipelines (World), 2010
Pharma-biotech Alliances: Licensing Deals by Therapeutic Area (World), 2008-2010
Pharma-biotech Alliances: Drugs in Development by Therapeutic Area (World), 2008-2010
Pharma-biotech Alliances: Merck - Percentage of Partnered Products Versus Average Sales (World), 2008-2009
Pharma-biotech Alliances: Current Drug Candidates in Product Pipeline (World), 2010
Pharma-biotech Alliances: Revenues Obtained from Sales of Pfizer Products By Year (World), 2007-2009
Pharma-biotech Alliances: Percentage of Partnered Drug Candidates by Therapeutic Area (World), 2008-2010
Pharma-biotech Alliances: Percentage of Drug Candidates in Various Therapeutic Areas by Stage of Drug Development (World), 2010
Pharma-biotech Alliances: Molecules from Partnerships as of April 2009
Pharma-biotech Alliances: Current Drug Candidates in Product Pipeline (World), 2010

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Biopharmaceuticals Markets in China

Biopharmaceuticals Markets in China

  • $ 4 000
  • Industry report
  • July 2015
  • by Asia Market Information & Development Company

China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...

Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2015

Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2015

  • $ 2 995
  • Industry report
  • June 2015
  • by Currentpartnering

The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the asset purchase agreements entered into by the worlds ...

Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025

Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025

  • $ 2 676
  • Industry report
  • May 2015
  • by Visiongain

Report Details Emerging Biological Drugs – This New Study Reveals Selling Opportunities and Revenue Prospects to Help You Stay Ahead What’s the future of biologics, especially new drug classes? Get ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.